Search

Your search keyword '"Mohammed, Rezika"' showing total 49 results

Search Constraints

Start Over You searched for: Author "Mohammed, Rezika" Remove constraint Author: "Mohammed, Rezika" Language english Remove constraint Language: english
49 results on '"Mohammed, Rezika"'

Search Results

1. Persistent T cell unresponsiveness associated with chronic visceral leishmaniasis in HIV-coinfected patients

2. Genomic analysis of Plasmodium vivax describes patterns of connectivity and putative drivers of adaptation in Ethiopia

3. A molecular barcode and web-based data analysis tool to identify imported Plasmodium vivax malaria

8. Population pharmacokinetics of a combination of miltefosine and paromomycin in Eastern African children and adults with visceral leishmaniasis.

11. Persistent T cell unresponsiveness associated with chronic VL disease in VL-HIV patients

12. Atypical Mucocutaneous Leishmaniasis Presentation Mimicking Rectal Cancer

13. Safety and Effectiveness of Sodium Stibogluconate and Paromomycin Combination for the Treatment of Visceral Leishmaniasis in Eastern Africa: Results from a Pharmacovigilance Programme

15. Detection of asymptomatic Leishmania infection in blood donors at two blood banks in Ethiopia.

16. PCR for detection of Leishmania donovani from microscopically negative tissue smears of suspected patients in Gondar, Ethiopia.

17. Paromomycin and Miltefosine Combination as an Alternative to Treat Patients With Visceral Leishmaniasis in Eastern Africa: A Randomized, Controlled, Multicountry Trial.

18. An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples

20. Outcomes and Predictors of Severe Community-acquired Pneumonia Among Adults Admitted to the University of Gondar Comprehensive Specialized Hospital: A Prospective Follow-up Study.

21. Snakebite case management: a cohort study in Northwest Ethiopia, 2012-2020.

22. COVID‐19 vaccine acceptability among healthcare workers in Ethiopia: Do we practice what we preach?

23. Aetiologies of acute undifferentiated febrile illness at the emergency ward of the University of Gondar Hospital, Ethiopia.

24. Evaluation of the CL Detect Rapid Test in Ethiopian patients suspected for Cutaneous Leishmaniasis.

25. Assessment of liver function test and associated factors among visceral leishmaniasis patients attending university of gondar leishmaniasis research and treatment center, Northwest Ethiopia.

26. Assessment of serum amylase, lipase and associated factors among patients with visceral leishmaniasis treated with sodium stibogluconate/paromomycin at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia.

27. Efficacy and safety of a combined treatment of sodium stibogluconate at 20mg/kg/day with upper maximum daily dose limit of 850mg and Paromomycin 15mg/kg/day in HIV negative visceral leishmaniasis patients. A retrospective study, northwest Ethiopia.

28. Miltefosine for the treatment of cutaneous leishmaniasis—A pilot study from Ethiopia.

29. A Ten-Year Trend of Cutaneous Leishmaniasis at University of Gondar Hospital, Northwest Ethiopia: 2009-2018.

30. Abdominal ultrasound in the diagnostic work-up of visceral leishmaniasis and for detection of complications of spleen aspiration.

32. Shigella Bacteremia in a Patient with Visceral Leishmaniasis

34. Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia.

35. Long-term Clinical Outcomes in Visceral Leishmaniasis/ Human Immunodeficiency Virus-Coinfected Patients During and After Pentamidine Secondary Prophylaxis in Ethiopia: A Single-Arm Clinical Trial.

36. Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia.

37. Use of Pentamidine As Secondary Prophylaxis to Prevent Visceral Leishmaniasis Relapse in HIV Infected Patients, the First Twelve Months of a Prospective Cohort Study.

38. Impact of the Use of a Rapid Diagnostic Test for Visceral Leishmaniasis on Clinical Practice in Ethiopia: A Retrospective Study.

39. High Parasitological Failure Rate of Visceral Leishmaniasis to Sodium Stibogluconate among HIV Co-infected Adults in Ethiopia.

40. Bacterial Sepsis in Patients with Visceral Leishmaniasis in Northwest Ethiopia.

41. Multiple Relapses of Visceral Leishmaniasis in HIV Co-Infected Patients: A Case Series from Ethiopia.

42. Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?

43. Atypical manifestations of visceral leishmaniasis in patients with HIV in north Ethiopia: a gap in guidelines for the management of opportunistic infections in resource poor settings.

44. A preliminary indication that HLA-A*03:01 may be associated with visceral leishmaniasis development in people living with HIV in Ethiopia.

45. Disease-specific differences in pharmacokinetics of paromomycin and miltefosine between post-kala-azar dermal leishmaniasis and visceral leishmaniasis patients in eastern Africa.

46. Efficacy, Safety, Tolerability, and Pharmacokinetics of MMV390048 in Acute Uncomplicated Malaria.

47. An open dataset of Plasmodium vivax genome variation in 1,895 worldwide samples.

48. Single-Dose Tafenoquine to Prevent Relapse of Plasmodium vivax Malaria.

49. Tuberculosis in Visceral Leishmaniasis-Human Immunodeficiency Virus Coinfection: An Evidence Gap in Improving Patient Outcomes?

Catalog

Books, media, physical & digital resources